Tenofovir Alafenamide Tablets IP 25 Mg – GENTUZA AF 25 Tablets

GENTUZA AF 25 Tablets – Trusted Protection in Chronic Hepatitis B & HIV.

GENTUZA AF 25 Tablets – Tenofovir Alafenamide Tablets IP 25 mg is an advanced antiviral medicine specifically used in the treatment of Hepatitis B viral infection and HIV-1 infection. Belonging to the nucleotide reverse transcriptase inhibitor (NtRTI) class, it works by blocking viral replication, reducing the viral load in the body, and helping maintain immune function. Compared to older tenofovir formulations, it offers enhanced efficacy at a lower dose with significantly reduced risks of kidney and bone-related side effects.

Key Benefits of Tenofovir Alafenamide Tablets – GENTUZA AF 25 Tablets
✅ Potent Antiviral Action – Effectively suppresses replication of HIV-1 and Hepatitis B virus.
✅ Improved Safety Profile – Lower plasma exposure compared to Tenofovir Disoproxil Fumarate (TDF), reducing risk of renal and bone toxicity.
✅ Convenient Once-Daily Dosing – Enhances adherence and long-term treatment success.

Recommended By Specialists:
👨‍⚕️ HIV Specialists: For managing HIV-1 infection in adults and adolescents.
👨‍⚕️ Hepatologists & Gastroenterologists: For chronic Hepatitis B virus (HBV) infection management.
👨‍⚕️ General Physicians: For ongoing antiretroviral or antiviral therapy.

INDICATIONS:
✅ Chronic Hepatitis B Infection
✅ HIV-1 Management (in combination regimens)
✅ HBV Reactivation Prophylaxis
✅ Renal-Safe Option (TAF preferred)
✅ ART Regimen Backbone